Methotrexate: new indication. Idiopathic juvenile arthritis: the standard immunosuppressant. Lengthy follow-up, but mediocre comparative assessment.
D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D017277:Drug Approval; D005602:France; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D007166:Immunosuppressive Agents; D008727:Methotrexate